GTS Securities LLC Lowers Stake in SPDR S&P Biotech ETF $XBI

GTS Securities LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,482 shares of the exchange traded fund’s stock after selling 3,638 shares during the period. GTS Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $3,400,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in XBI. AQR Capital Management LLC grew its stake in SPDR S&P Biotech ETF by 77.1% in the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after acquiring an additional 2,167 shares in the last quarter. Marshall Wace LLP increased its position in shares of SPDR S&P Biotech ETF by 102.3% during the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after acquiring an additional 179,029 shares during the period. The Manufacturers Life Insurance Company bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $260,000. Ameriprise Financial Inc. raised its stake in shares of SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after acquiring an additional 481,408 shares in the last quarter. Finally, EP Wealth Advisors LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 3.7% in the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after purchasing an additional 193 shares during the period.

SPDR S&P Biotech ETF Stock Down 3.5%

Shares of NYSEARCA:XBI opened at $162.38 on Friday. SPDR S&P Biotech ETF has a 52-week low of $89.33 and a 52-week high of $169.89. The stock has a market cap of $10.60 billion, a P/E ratio of 11.47 and a beta of 0.83. The business’s 50 day moving average is $156.78 and its 200 day moving average is $139.13.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.